Thu, Apr 17, 2014, 10:40 AM EDT - U.S. Markets close in 5 hrs 20 mins

Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

beachinv 9 posts  |  Last Activity: Mar 14, 2014 12:59 AM Member since: Oct 4, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Hope shorts keep shorting - more fuel for the fire...:)

  • Just a bad biotech tape lately...no issues here as fundamentals have never been better with strong institutional support. This will be a snap back to test $30 and slow grind to $40 but will happen in next couple months imo. The only real positive biotech movers on my tape today were TSRO and INSM. Both also have solid catalysts in near term with lots upside....

  • Reply to

    Deutsche Bank out with $72.00 price target

    by zonin.amarone Mar 13, 2014 3:49 PM
    beachinv beachinv Mar 13, 2014 7:19 PM Flag

    I have been long just recently- look for continued runup as shorts trapped here (only 18mil float) with 2 mil shrs short. Big squeeze coming as we and a few others are adding...:) dangerous game here for shorts as institutions will be adding as fundamentals are good here with their existing positive phase 3 data and the global licensing deal for portfolio of antibodies for cancer immunotherapies just puts this stock much too cheap. Shorts will be scrambling over $50 soon. Check out INSM also been a long holder of this one - moving up on heavy volume today ahead of clinical trials for NTM lung infections in next 2 wks. Think data will be positive as they have history of positive data with the product even in phase 3 trials for CF patients....look for big move up in INSM also....:)

  • Given the drug platform and upcoming catalysts I like the potential for NTM and CF. Stay the course and understand the drug and previous trial results. Don't pay too much attention to the noise and you will see how attractive this investment is based on risk/reward. Lets see who is correct by next month....:) GL to all even the shorts...lol

  • Reply to

    Buying opportunity for people who were left out.

    by levonchiko Feb 11, 2014 12:27 PM
    beachinv beachinv Feb 11, 2014 1:16 PM Flag

    Agreed here. There has been no news just based on analyst opinion basically saying that he was somewhat wrong before...Think there are other motives here as Wedbush was one of the few firms left out in the last fundraising round...:) Perhaps some sour grapes for not getting any banking fees? Also their pt doesn't make sense as they didn't come out and say that they thought data would be negative for NTM. There is limited options for patients suffering from NTM so with positive data from upcoming trial I believe FDA will work with the company to make this available to the public quickly...Today is a buying opportunity imo. GL to all

  • This will be fun as there are lots more upside from these levels. Look at valuation, this could easily be over 400 mil mkt cap. Very attractive assets also for many suitors....:)

  • beachinv beachinv Feb 4, 2014 11:20 AM Flag

    Much too quiet here...Think good levels to add again. Will not stay that way for too long...:)

  • We and others are accumulating shares. Shorts caught off guard as long as they are stubborn we will have sharp spikes up....:) Big surprise for the shorts soon....

  • Overall mkt has been weak but select biotech will still outperform this year as pharma races to expand their current weak drug pipeline and will see more deals. FDA has been very active in allowing novel drugs that show efficacy for indications with little treatment options. INSM continues to be my top holding- we have been through many cycles with this company and I believe that we are about to enter more commercialization phase with upcoming positive surprises even non-Arikace...:) My feeling is that many will look back and wonder why they didn't invest more $$$ here as Lewis will soon turn this company into multi-Billion $ biopharma. Look back at my previous posts I have been very transparent in my views and outlook. Stay the course as our investment here will really accelerate higher imho...Good luck to all and invest based on your analysis and diligence these opportunities will not always present themselves....:)

AEGR
44.50+0.98(+2.25%)10:40 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.